Study of ONO-4538 in Gastric Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

680

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

November 17, 2022

Conditions
Gastric Cancer
Interventions
DRUG

ONO-4538

DRUG

Oxaliplatin

DRUG

Tegafur- Gimeracil-Oteracil potassium

DRUG

Capecitabine

DRUG

Placebo

Trial Locations (130)

Unknown

Aichi Clinical Site, Nagoya

Aomori Clinical Site, Hirosaki

Aomori Clinical Site, Misawa

Chiba Clinical Site, Funabashi

Chiba Clinical Site, Kamogawa

Chiba Clinical Site, Kashiwa

Ehime Clinical Site1, Matsuyama

Ehime Clinical Site2, Matsuyama

Fukuoka Clinical Site, Iizuka

Fukuoka Clinical Site1, Kitakyushu

Fukuoka Clinical Site2, Kitakyushu

Fukuoka Clinical Site, Kurume

Gifu Clinical Site, Gifu

Gifu Clinical Site, Ōgaki

Gumma Clinical Site, Maebashi

Gunma Clinical Site, Ōta

Gumma Clinical Site, Takasaki

Hiroshima Clinical Site, Kure

Hokkaido Clinical Site, Hakodate

Hokkaido Clinical Site1, Sapporo

Hokkaido Clinical Site2, Sapporo

Hokkaido Clinical Site3, Sapporo

Hokkaido Clinical Site4, Sapporo

Hyogo Clinical Site, Akashi

Hyogo Clinical Site, Amagasaki

Hyogo Clinical Site, Kobe

Hyogo Clinical Site, Nishinomiya

Ibaraki Clinical Site, Higashiibaraki-gun

Ibaraki Clinical Site, Tsuchiura-shi

Ishikawa Clinical Site1, Kanazawa

Ishikawa Clinical Site2, Kanazawa

Iwate Clinical Site, Morioka

Kagawa Clinical Site, Kita-gun

Kanagawa Clinical Site, Isehara

Kanagawa Clinical Site, Kamakura

Kanagawa Clinical Site, Sagamihara

Kanagawa Clinical Site1, Yokohama

Kanagawa Clinical Site2, Yokohama

Kanagawa Clinical Site3, Yokohama

Miyagi Clinical Site, Natori-shi

Miyagi Clinical Site, Ōsaki

Miyagi Clinical Site, Sendai

Nagano Clinical Site, Saku

Nara Clinical Site, Ikoma

Nara Clinical Site, Kashihara-shi

Okayama Clinical Site, Kurashiki

Osaka Clinical Site, Izumi

Osaka Clinical Site, Sakai

Osaka Clinical Site, Sayama

Osaka Clinical Site, Suita

Osaka Clinical Site, Takatsuki

Osaka Clinical Site, Toyonaka

Saitama Clinical Site, Hidaka

Saitama Clinical Site, Kitaadachi-gun

Shizuoka Clinical Site, Hamamatsu

Tochigi Clinical Site, Shimotsuke

Tochigi Clinical Site, Utsunomiya

Tokyo Clinical Site, Bunkyo-ku

Tokyo Clinical Site, Chuo-ku

Tokyo Clinical Site, Fuchū

Tokyo Clinical Site, Koto-ku

Tokyo Clinical Site, Minato-ku

Tokyo Clinical Site, Shinagawa-ku

Tokyo Clinical Site1, Shinjuku-ku

Tokyo Clinical Site2, Shinjuku-ku

Tokyo Clinical Site, Tachikawa

Tottori Clinical Site, Yonago

Yamagata Clinical Site, Sakata

Akita Clinical Site, Akita

Chiba Clinical Site1, Chiba

Chiba Clinical Site2, Chiba

Fukui Clinical Site, Fukui

Fukuoka Clinical Site1, Fukuoka

Fukuoka Clinical Site2, Fukuoka

Fukuoka Clinical Site3, Fukuoka

Fukuoka Clinical Site4, Fukuoka

Fukushima Clinical Site, Fukushima

Hiroshima Clinical Site1, Hiroshima

Hiroshima Clinical Site2, Hiroshima

Hiroshima Clinical Site3, Hiroshima

Kumamoto Clinical Site1, Kumamoto

Kumamoto Clinical Site2, Kumamoto

Kumamoto Clinical Site3, Kumamoto

Kyoto Clinical Site1, Kyoto

Kyoto Clinical Site2, Kyoto

Kyoto Clinical Site3, Kyoto

Niigata Clinical Site, Niigata

Okayama Clinical Site, Okayama

Osaka Clinical Site1, Osaka

Osaka Clinical Site2, Osaka

Osaka Clinical Site3, Osaka

Osaka Clinical Site4, Osaka

Shizuoka Clinical Site, Shizuoka

Tokushima Clinical Site, Tokushima

Toyama Clinical Site, Toyama

Wakayama Clinical Site, Wakayama

Yamagata Clinical Site, Yamagata

Gyeongnam Clinical Site, Gyeongnam

Busan Clinical Site, Busan

Daegu Clinical Site 1, Daegu

Daegu Clinical Site 2, Daegu

Daejeon Clinical Site, Daejeon

Gyeonggi-Do Clinical Site1, Gyeonggi-do

Gyeonggi-Do Clinical Site2, Gyeonggi-do

Gyeonggi-Do Clinical Site3, Gyeonggi-do

Gyeonggi-Do Clinical Site4, Gyeonggi-do

Gyeonggi-Do Clinical Site5, Gyeonggi-do

Incheon Clinical Site, Incheon

Jeollabuk-Do Clinical Site, Jeollabuk-Do

Jeollanam-do Clinical Site, Jeollanam-do

Seoul Clinical Site 1, Seoul

Seoul Clinical Site 2, Seoul

Seoul Clinical Site 3, Seoul

Seoul Clinical Site 4, Seoul

Seoul Clinical Site 5, Seoul

Seoul Clinical Site 6, Seoul

Seoul Clinical Site7, Seoul

Seoul Clinical Site8, Seoul

Seoul Clinical Site9, Seoul

Ulsan Clinical Site, Ulsan

Kaohsiung Clinical Site1, Kaohsiung City

Kaohsiung Clinical Site2, Kaohsiung City

New Taipei Clinical Site 1, New Taipei City

Taichung Clinical Site 1, Taichung

Taichung Clinical Site2, Taichung

Tainan Clinical Site1, Tainan City

Tainan Clinical Site2, Tainan City

Taipei Clinical Site1, Taipei

Taipei Clinical Site2, Taipei

Taoyuan Clinical Site, Taoyuan District

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY